Bioxytran, Inc.
BIXT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5 | $26 | $295 | $72 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $5 | $26 | $295 | $72 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $134 | $113 | $76 | $47 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $134 | $113 | $76 | $47 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $139 | $138 | $371 | $119 |
| Liabilities | – | – | – | – |
| Payables | $0 | $2 | $1 | $0 |
| Short-Term Debt | $1,094 | $1,925 | $2,165 | $2,122 |
| Tax Payable | $12 | $0 | $40 | $32 |
| Deferred Revenue | $0 | $0 | $0 | -$531 |
| Other Curr. Liab. | $824 | $1,325 | $1,457 | $1,123 |
| Total Curr. Liab. | $1,931 | $3,244 | $3,663 | $3,277 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $3 | $0 |
| Other Liabilities | $0 | $0 | -$3 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $1,931 | $3,250 | $3,663 | $3,277 |
| Equity | – | – | – | – |
| Pref Stock | $43 | $0 | $0 | $0 |
| Common Stock | $87 | $146 | $123 | $111 |
| Retained Earnings | -$18,921 | -$15,498 | -$11,218 | -$8,754 |
| AOCI | $0 | $0 | $0 | -$0 |
| Other Equity | $16,999 | $12,921 | $8,392 | $5,882 |
| Total Equity | -$1,792 | -$2,431 | -$2,702 | -$2,761 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | -$681 | -$591 | -$397 |
| Total Liab. & Tot. Equity | $139 | $138 | $371 | $119 |
| Net Debt | $1,089 | $1,899 | $1,870 | $2,050 |